Highnoon Laboratories Ltd
Nimra W. is an experienced professional in the pharmaceutical and production sectors, currently serving as a Senior Officer in Production at Highnoon since February 2021, where responsibilities include investigating and establishing quality and health safety standards while ensuring compliance with manufacturing processes. Prior to this role, Nimra held positions as a Pharmacy Practice Resident at Children Hospital Lahore and completed internships at Himont Pharmaceuticals (Pvt) Ltd. and Fazal Din & Sons Group, where Nimra worked as a Pharmacy Intern and Retail Pharmacist, respectively. Educational qualifications include a Doctor of Pharmacy (Pharm.D.) from Lahore College for Women University and an Intermediate degree from Pakistan International School in Riyadh, Saudi Arabia.
This person is not in any teams
Highnoon Laboratories Ltd
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.